📰 Amgen News
Page 93 - Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amgen. Real-time updates on events, politics, business and more.
March 31, 2024
Fulcrum Equity Management reduced its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 7.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,859 shares of the medical research company’s stock after selling 142 shares during the quarter. Fulcrum Equity Management’s holdings in Amgen […]
March 31, 2024
Strategic Advisors LLC raised its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,642 shares of the medical research company’s stock after purchasing an additional 51 shares during the quarter. Amgen accounts for […]
March 31, 2024
JP Morgan's 'No Zoom' Policy Tested As Big Firms Skip Health Conference : Rashtra News Jamie Dimon has praised technology such as Zoom for keeping business going during temporary lockdowns.Few of the corporate world's most prominent leaders have been as effusive this year as Jamie Dimon in cajoling office workers back into pre-pandemic routines, arguing
March 31, 2024
The e-commerce veteran will be bigger, better, and more profitable, with a few surprises.
March 31, 2024
BLB&B Advisors LLC grew its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,889 shares of the medical research company’s stock after buying an additional 111 shares during the period. BLB&B Advisors LLC’s […]
March 31, 2024
The e-commerce veteran will be bigger, better, and more profitable, with a few surprises.
March 31, 2024
Atlas Private Wealth Management acquired a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 715 shares of the medical research company’s stock, valued at approximately $206,000. Other large investors have also made […]
March 31, 2024
Hengehold Capital Management LLC trimmed its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 11.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,350 shares of the medical research company’s stock after selling 167 shares during the quarter. Hengehold Capital Management LLC’s holdings in Amgen were worth $389,000 as of […]
March 31, 2024
Hengehold Capital Management LLC cut its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 11.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,350 shares of the medical research company’s stock after selling 167 shares during the quarter. Hengehold Capital Management LLC’s […]
March 31, 2024
Atlas Private Wealth Management bought a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 715 shares of the medical research company’s stock, valued at approximately $206,000. Other large investors have also recently modified their holdings […]